Richard Durbin actually said...
What we can do is to make sure that if profits ensue and NIH has made a contribution to that, in terms of genuine intellectual property discoveries, that there should be royalty sharing on that basis.
Context
Durbin discusses the need for royalty sharing from NIH contributions to drug development.
03/08/2011